Shanghai Shyndec Pharmaceutical Co Ltd (600420) — Cash Flow Reinvestment Rate
Shanghai Shyndec Pharmaceutical Co Ltd (600420) has a Cash Flow Reinvestment Rate of 0.14x as of September 2025, reinvesting CN¥67.11 Million (capex CN¥67.11 Million ) from operating cash flow of CN¥486.04 Million. Check earnings quality score of Shanghai Shyndec Pharmaceutical Co Ltd to evaluate the quality of earnings relative to operating cash generation.
Reinvestment Rate
Total Reinvested
Operating Cash Flow
Capital Expenditures
Shanghai Shyndec Pharmaceutical Co Ltd Cash Flow Reinvestment Rate (2004–2025)
Historical reinvestment intensity for Shanghai Shyndec Pharmaceutical Co Ltd across 22 annual periods. Explore Shanghai Shyndec Pharmaceutical Co Ltd long-term investment allocation to see how much of total assets are deployed in long-term investments.
Annual Cash Flow Reinvestment Rate for Shanghai Shyndec Pharmaceutical Co Ltd (2004–2025)
Year-by-year capital reinvestment analysis for Shanghai Shyndec Pharmaceutical Co Ltd. For live market cap and broader valuation context, see 600420 market cap overview.
| Year | Reinvestment Rate | Total Reinvested (CNY) | Operating CF | Capex | YoY Change |
|---|---|---|---|---|---|
| 2025 | 0.18x | CN¥305.40 Million | CN¥1.70 Billion | CN¥263.83 Million | ▲ +69.1% |
| 2024 | 0.11x | CN¥239.87 Million | CN¥2.26 Billion | CN¥219.77 Million | ▼ -83.9% |
| 2023 | 0.66x | CN¥1.14 Billion | CN¥1.72 Billion | CN¥357.19 Million | ▲ +209.3% |
| 2022 | 0.21x | CN¥609.88 Million | CN¥2.86 Billion | CN¥307.44 Million | ▼ -31.4% |
| 2021 | 0.31x | CN¥522.58 Million | CN¥1.68 Billion | CN¥521.44 Million | ▼ -17.1% |
| 2020 | 0.38x | CN¥585.79 Million | CN¥1.56 Billion | CN¥377.98 Million | ▲ +16.8% |
| 2019 | 0.32x | CN¥408.42 Million | CN¥1.27 Billion | CN¥403.82 Million | ▼ -30.6% |
| 2018 | 0.46x | CN¥772.95 Million | CN¥1.67 Billion | CN¥399.40 Million | ▲ +523.4% |
| 2017 | 0.07x | CN¥171.94 Million | CN¥2.31 Billion | CN¥168.44 Million | ▼ -79.6% |
| 2016 | 0.36x | CN¥305.85 Million | CN¥838.58 Million | CN¥241.30 Million | ▼ -69.6% |
| 2015 | 1.20x | CN¥271.86 Million | CN¥226.65 Million | CN¥234.52 Million | ▼ -28.0% |
| 2014 | 1.67x | CN¥430.53 Million | CN¥258.51 Million | CN¥430.53 Million | ▼ -32.6% |
| 2013 | 2.47x | CN¥512.62 Million | CN¥207.50 Million | CN¥512.62 Million | ▲ +17.8% |
| 2012 | 2.10x | CN¥405.52 Million | CN¥193.41 Million | CN¥405.52 Million | ▲ +122.3% |
| 2011 | 0.94x | CN¥128.40 Million | CN¥136.12 Million | CN¥128.40 Million | ▼ -30.4% |
| 2010 | 1.36x | CN¥156.02 Million | CN¥115.11 Million | CN¥156.02 Million | ▲ +322.0% |
| 2009 | 0.32x | CN¥31.29 Million | CN¥97.43 Million | CN¥31.29 Million | ▲ +37.5% |
| 2008 | 0.23x | CN¥13.56 Million | CN¥58.04 Million | CN¥13.56 Million | ▼ -44.2% |
| 2007 | 0.42x | CN¥34.45 Million | CN¥82.31 Million | CN¥34.45 Million | ▼ -50.3% |
| 2006 | 0.84x | CN¥62.00 Million | CN¥73.60 Million | CN¥62.00 Million | ▼ -31.9% |
| 2005 | 1.24x | CN¥71.65 Million | CN¥57.90 Million | CN¥71.65 Million | ▲ +33.4% |
| 2004 | 0.93x | CN¥15.79 Million | CN¥17.02 Million | CN¥15.79 Million | — |